Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1981;57:199-202
© 1981 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SIBAl, B M
Right arrow Articles by DILTS, P V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIBAl, B M
Right arrow Articles by DILTS, P V, Jr

Reassessment of Intravenous MgSO4 Therapy in Preeclampsia–Eclampsia

B M SIBAl, MD, J. LIPSHITZ, MB, ChB, G D ANDERSON, MD and P V DILTS, Jr, MD

From the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Tennessee College of Medicine, Memphis, TN

Abstract

The occurrence of seizures in preeclamptic and eclamptic women is considered very unlikely during treatment with the standard dose of continuous intravenous magnesium sulfate. During a 21-month period, the authors encountered 13 patients who developed seizure activity while receiving intravenous MgSO4. Serum magnesium (Mg) levels at the time of seizure were below the therapeutic range in 11 of the 13 patients, thus prompting a study of serum Mg levels in preeclamptic patients treated with MgSO4. Random serum Mg samples were obtained from 120 patients treated with intravenous MgSO4 for preeclampsia-eclampsia. The samples were collected 2 to 48 hours after the loading dose and while the patients were taking a maintenance dose of either 1, 2, or 3 g/hr. When a maintenance dose of 1 or 2 g/ hr was used, 98 and 50% of the respective serum magnesium values were below levels considered therapeutic by several authors. Therapeutic levels were achieved in all patients receiving a maintenance dose of 3 g/hr. The recommended maintenance dose of MgSO4 of 1 g/hr was found insufficient to prevent the occurrence of eclamptic seizures in some preeclamptic patients.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Wadhwa, P. Sengupta, J. Durrani, O. Akca, R. Lenhardt, D. I. Sessler, and A. G. Doufas
Magnesium sulphate only slightly reduces the shivering threshold in humans
Br. J. Anaesth., June 1, 2005; 94(6): 756 - 762.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. M Roberts, J. Villar, and S. Arulkumaran
Preventing and treating eclamptic seizures
BMJ, September 21, 2002; 325(7365): 609 - 610.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American College of Obstetricians and Gynecologists.